EP 0675723 A1 19951011 - BISPHOSPHONATE/ESTROGEN THERAPY FOR TREATING AND PREVENTING BONE LOSS.
Title (en)
BISPHOSPHONATE/ESTROGEN THERAPY FOR TREATING AND PREVENTING BONE LOSS.
Title (de)
BIPHOSPHONAT/ÖSTROGEN-THERAPIE ZUR BEHANDLUNG UND PRÄVENTION VON KNOCHENVERLUST.
Title (fr)
THERAPIE UTILISANT DES BISPHOSPHONATES ET DES STROGENES EN VUE DE TRAITER ET DE PREVENIR LA RESORPTION OSSEUSE.
Publication
Application
Priority
- US 9312302 W 19931217
- US 99641892 A 19921223
Abstract (en)
[origin: WO9414455A1] Disclosed is a combination therapy for treating and for preventing bone loss by the use of estrogen and a bisphosphonate selected from: alendronate, clodronate, tiludronate, YM175, BM210995, or mixture thereof. Also described is a pharmaceutical composition of the above for carrying out the therapeutic method.
IPC 1-7
IPC 8 full level
A61K 31/565 (2006.01); A61K 31/66 (2006.01); A61P 43/00 (2006.01)
CPC (source: EP)
A61K 31/66 (2013.01); A61P 43/00 (2017.12)
Designated contracting state (EPC)
AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE
DOCDB simple family (publication)
WO 9414455 A1 19940707; AU 5953894 A 19940719; CA 2151240 A1 19940707; EP 0675723 A1 19951011; EP 0675723 A4 19980805; JP H08505142 A 19960604
DOCDB simple family (application)
US 9312302 W 19931217; AU 5953894 A 19931217; CA 2151240 A 19931217; EP 94905419 A 19931217; JP 51531294 A 19931217